Detalhe da pesquisa
1.
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
N Engl J Med
; 382(23): 2187-2196, 2020 06 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32469183
2.
A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study.
Jpn J Clin Oncol
; 52(2): 187-196, 2022 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34698353
3.
Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries.
Cancer Sci
; 112(6): 2071-2080, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33738901
4.
Long-term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old.
Cancer Sci
; 112(8): 3074-3082, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34014592
5.
Cost-effectiveness analysis of enzalutamide for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer in Japan.
Jpn J Clin Oncol
; 51(8): 1319-1329, 2021 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34037235
6.
Dynamics of conditional survival and risk factors in androgen deprivation therapy for prostate cancer using a multi-institutional Japan-wide database.
Int J Urol
; 28(9): 927-935, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34028097
7.
Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database.
Int J Urol
; 28(5): 584-591, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33629386
8.
[Current Clinical Practice Pattern for Castration-Resistant Prostate Cancer(CRPC)in Japan].
Gan To Kagaku Ryoho
; 48(11): 1359-1363, 2021 Nov.
Artigo
Japonês
| MEDLINE | ID: mdl-34795127
9.
Primary Androgen-Depletion Therapy Prevails Not Only for Metastatic but Also for Nonmetastatic Hormone-Naïve Prostate Cancer in Japan-Recent Trends and Efficacy.
Gan To Kagaku Ryoho
; 48(7): 911-919, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34267028
10.
Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study.
Jpn J Clin Oncol
; 50(8): 940-947, 2020 Aug 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32458996
11.
Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.
Int J Clin Oncol
; 25(6): 1163-1169, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32125546
12.
Family history in primary hormone therapy for prostate cancer: Analysis from a community-based multi-institutional Japan-wide database.
Int J Urol
; 27(4): 313-318, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32037622
13.
Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.
BJU Int
; 123(1): 22-34, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30019467
14.
Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.
Jpn J Clin Oncol
; 49(10): 956-964, 2019 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31135920
15.
Report of the forth Asian Prostate Cancer (A-CaP) study meeting.
Jpn J Clin Oncol
; 49(6): 581-586, 2019 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31141613
16.
[The 2nd Japan Public-Private Dialogue Forum-A Multi-Stakeholder Dialogue on Universal Health Coverage for Cancer in Asia-Seeking an Approach to Asia Health and Wellbeing Initiative].
Gan To Kagaku Ryoho
; 46(4): 655-671, 2019 Apr.
Artigo
Japonês
| MEDLINE | ID: mdl-31164504
17.
Efficacy and safety of 3-month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study.
Cancer Sci
; 109(6): 1920-1929, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29624800
18.
Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis.
Br J Cancer
; 119(2): 241-247, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29891937
19.
NCCN Asia Consensus Statement prostate cancer.
Jpn J Clin Oncol
; 48(11): 964-965, 2018 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30184146
20.
Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan.
Int J Clin Oncol
; 23(6): 1140-1147, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29971622